Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2010
08/12/2010US20100203061 Prevention and treatment of retinal ischemia and edema
08/12/2010US20100203060 Inhibitors for growth hormone and related hormones, and methods of use thereof
08/12/2010US20100203059 Method of treating a pathological syndrome and a pharmaceutical agent
08/12/2010US20100203057 Novel compounds
08/12/2010US20100203056 Anti-pd-l1 antibodies and their use to enhance t-cell function
08/12/2010US20100203053 Method and composition for treating immune complex associated disorders
08/12/2010US20100203052 Binding domain-immunoglobulin fusion proteins
08/12/2010US20100203049 Interleukin-10 Antibodies
08/12/2010US20100203047 Novel Compositions And Methods For Stimulating Erythropoiesis In A Mammal
08/12/2010US20100203046 Fc gamma receptor-binding polypeptide variants and methods related thereto
08/12/2010US20100203045 EPH RECEPTOR Fc VARIANTS WITH ENHANCED ANTIBODY DEPENDENT CELL-MEDIATED CYTOTOXICITY ACTIVITY
08/12/2010US20100203044 Dr6 antagonists and uses thereof in treating neurological disorders
08/12/2010US20100203042 Recombinant anti-vla4 antibody molecules
08/12/2010US20100203041 Antibodies to egfl7 and methods for their use
08/12/2010US20100203040 Genetic Products Which are Differentially Expressed in Tumors and Use Thereof
08/12/2010US20100203036 Targets for tumor growth inhibition
08/12/2010US20100203035 B7-h3 in cancer
08/12/2010US20100203011 Mammalian Cytokines; Related Reagents and Methods
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/12/2010US20100202972 Use of gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls)
08/12/2010US20100202968 Method of Providing Disease-Specific Binding Molecules and Targets
08/12/2010US20100202964 Organ Homing Genes of Cancer Metastases
08/12/2010US20100202962 Cripto blocking antibodies and uses thereof
08/12/2010CA2751571A1 Sam-6 variants, target and methods of use
08/12/2010CA2751433A1 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
08/12/2010CA2750977A1 Immunoglobulin glycosylation pattern analysis
08/11/2010EP2216651A1 Biomarker for diagnosis of liver disease
08/11/2010EP2216650A1 Real time method of detecting acute inflammatory conditions
08/11/2010EP2216414A1 Cell-free translation system
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216344A1 Diagnosis and treatment of cancer using anti-gpr49 antibody
08/11/2010EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/11/2010EP2216342A1 Anti-CD19 antibodies
08/11/2010EP2216046A2 Anti-glypican 3 antibody
08/11/2010EP2215474A2 Antibody therapy for modulating function of intestinal receptors
08/11/2010EP2215247A1 Production of cytotoxic antibody-toxin fusion in eukaryotic algae
08/11/2010EP2215125A1 Method for obtaining polypeptide constructs comprising two or more single domain antibodies
08/11/2010EP2215123A1 Immunoglobulin constructs
08/11/2010EP2215122A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof
08/11/2010EP2215121A1 Anti-mesothelin antibodies and uses therefor
08/11/2010EP2215120A2 Humanized antibody molecules specific for il-31
08/11/2010EP2215119A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
08/11/2010EP2215118A1 Antibodies to gdf8 as uses thereof
08/11/2010EP2215117A1 Antibody purification by cation exchange chromatography
08/11/2010EP2215116A1 The present invention relates to methods for prediction of the therapeutic success of breast cancer therapy
08/11/2010EP2214711A2 Anti-rsv g protein antibodies
08/11/2010EP2214706A1 Use of trkb antibodies for the treatment of respiratory disorders
08/11/2010EP2214705A2 A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
08/11/2010EP2214690A1 Melanocortin receptor binding mimetibodies, compositions, methods and uses
08/11/2010EP1984522B1 Methods of increasing lymphatic function
08/11/2010EP1827492B1 Antibodies directed to gpnmb and uses thereof
08/11/2010EP1716178B1 Less immunogenic binding molecules
08/11/2010EP1680141B1 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
08/11/2010EP1515750B1 Combinations comprising epothilones and pharmaceutical uses thereof
08/11/2010EP1489170B1 Transporter selectively transporting sulfate conjugate and its gene
08/11/2010EP1483294B1 Internalizing anti-cd74 antibodies and methods of use
08/11/2010EP1135415B1 Humanized antibodies to gamma-interferon
08/11/2010EP0988063B2 Process for reducing the concentration of viral and molecular pathogens in a biological material
08/11/2010CN101802211A Anti-RANTES antibodies and methods of use thereof
08/11/2010CN101802198A immunogenic polypeptides and monoclonal antibodies
08/11/2010CN101802197A Single-chain FC (ScFc) regions, binding polypeptides comprising same, and methods related thereto
08/11/2010CN101802193A Cancer diagnosis kit and cancer diagnosis method
08/11/2010CN101802192A Method for production of antibody
08/11/2010CN101802015A Bispecific antibodies and methods for production thereof
08/11/2010CN101802014A He4 monoclonal antibodies and methods for their use
08/11/2010CN101802013A Humanized anti-CD79b antibodies and immunoconjugates and methods of use
08/11/2010CN101802012A Anti-CD79b antibodies and immunoconjugates and methods of use
08/11/2010CN101802011A mdl-1 uses
08/11/2010CN101802010A recombinant, single-chain, trivalent tri-specific or bi-specific antibody derivatives
08/11/2010CN101802009A Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
08/11/2010CN101802008A Human C-FMS antigen binding proteins
08/11/2010CN101802007A Monoclonal anti-beta amyloid antibody
08/11/2010CN101802006A Display of binding agents
08/11/2010CN101802005A Compositions and methods comprising binding proteins for adalimumab
08/11/2010CN101802004A Polypeptides, antibody variable domains and antagonists
08/11/2010CN101802003A Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
08/11/2010CN101802002A Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
08/11/2010CN101799476A Reagent box for sieving autoantibody for tsh receptor
08/11/2010CN101798586A Process for producing aminated complex-type sugar chain derivatives
08/11/2010CN101798579A Jatropha curcas farnesyl pyrophosphate synthase protein encoding sequence and application thereof in plants
08/11/2010CN101798577A Jatropha curcas phytoene synthetase gene sequence and application thereof in plants
08/11/2010CN101798349A Anti-uPAR humanized antibody and coding gene thereof
08/11/2010CN101798348A Anti-uPAR humanized antibody and application thereof
08/11/2010CN101798347A Monoclonal antibody for resisting high mobility group protein B1
08/11/2010CN101797384A Tri-union compound immunopotentiator and method for preparing same
08/11/2010CN101007845B Method for screening high egg-yield fowl
08/10/2010US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis
08/10/2010US7772385 nucleotide sequences coding novel g-protein coupled receptors for identifying modulators of sweet taste transduction
08/10/2010US7772375 amyloidosis; neurological disorders such as Alzheimer's Disease
08/10/2010US7772374 monoclonal antibodies specific for Bacillus anthracis relative to the vegetative form of the cells; detecting the presence/absence of these spores
08/10/2010US7772373 Major histocompatibility complex specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, liver and kidney disorders
08/10/2010US7772372 Neoplasm specific antibodies and uses thereof
08/10/2010US7772187 Substances directed against a specific sequence essential for heparanase catalytic activity and uses thereof as heparanase inhibitors
08/10/2010US7771969 Methods for obtaining antibodies
08/10/2010US7771960 determining the presence or amount of feline pancreatic lipase in a biological sample; generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies
08/10/2010US7771959 Methods to determine the presence or amount of canine pancreatic lipase with antibodies
08/10/2010US7771958 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
08/10/2010US7771952 drug screening for an agent which modulates the binding of a Repulsive Guidance Molecule (RGM) to a Neogenin; for nervous system, angiogenic, cardiovascular system disorders
08/10/2010US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/10/2010US7771930 Identifying mutation in nucleotide sequences coding immunoglobulin domain carrying polypeptide for use in diagnosis and prognosis of cell proliferative disorders
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 1494